The effect of plasmapheresis on blood pressure in voluntary plasma donors

Por Rosa-Bray, M, Wisdom, C, Marier, J F, Mouksassi, M-S, Wada, S
Publicado no Vox Sang (2015)

Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate()

Por Lichter-Konecki, Uta, Diaz, G.A., Merritt, J.L., Feigenbaum, A., Jomphe, C., Marier, J.F., Beliveau, M., Mauney, J., Dickinson, K., Martinez, A., Mokhtarani, M., Scharschmidt, B., Rhead, W.
Publicado no Mol Genet Metab (2011)

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherap...

Por Thomas, M., Sadjadian, P., Kollmeier, J., Lowe, J., Mattson, P., Trout, J. R., Gargano, M., Patchen, M. L., Walsh, R., Beliveau, M., Marier, J. F., Bose, N., Gorden, K., Schneller, F.
Publicado no Invest New Drugs (2017)

Pharmacokinetic and Pharmacodynamic Modeling To Determine the Dose of ST-246 To Protect against Smallpox in Humans

Por Leeds, Janet M., Fenneteau, Frederique, Gosselin, Nathalie H., Mouksassi, Mohamad-Samer, Kassir, Nastya, Marier, J. F., Chen, Yali, Grosenbach, Doug, Frimm, Annie E., Honeychurch, Kady M., Chinsangaram, Jarasvech, Tyavanagimatt, Shanthakumar R., Hruby, Dennis E., Jordan, Robert
Publicado em 2013